Notably, the S100A9 expression rate increased significantly in classical monocytes but not in the intermediate CD14++/CD16+ and the nonclassical CD14+/CD16+ subsets in AIS patients (Figure 1B,C). Here, S100A9 is linked to androgen insensitivity syndrome.